Baystate moved in negotiations as nurses prepared to issue strike notice; agreement addresses patient safety, health insurance and competitive compensation GREENFIELD, Mass., Sept. 29, 2026 /PRNewswire/ -- Registered nurses at Baystate Franklin Medical Center (BFMC), represented by the...
Created by Cali with Insights From a Partnership with the Joan Ganz Cooney Center at Sesame Workshop LOS ANGELES, Sept. 29, 2026 /PRNewswire/ -- Cali, the female-founded children's brand bringing stories, songs and learning to life through interactive books, today announced the launch of...
HONG KONG, Sept 29, 2026 - (ACN Newswire) - Direct Drive Tech Limited ("Direct Drive Tech" or the "Company", stock code: 6731) was officially listed on the Main Board of The Stock Exchange of Hong Kong Limited. The Company offered 50,000,000 shares under the Global Offering, of which the Hong Kong Public Offering was approximately 208.56 times subscribed. The final offer price was set at HK$21.60 per share with a board lot of 100 shares, raising gross proceeds of approximately HK$1,080.0 million. "From day one, Direct Drive Tech has pursued a single goal — using direct drive technology to drive the world," founder Zhang Di said at the listing ceremony. "We remain committed to our mission of bringing robots into every household, and to making robots more efficient, more dexterous and more intelligent." In a letter to staff on the eve of the listing, Zhang likened the industry's shift to the replacement of vacuum tubes by transistors: "This time, the future will not belong to better reducers either." He expects at least 10 billion robots to enter industries and households over the next decade. Direct Drive Tech, he wrote, is not simply a maker of "direct drive joints", but a robotics technology company with direct drive technology at its core and general intelligence connecting everything, with future investment focused on three areas: AI4S (AI for Science), AI4I (AI for Iteration) and AI4R (AI for Robot). Direct Drive Tech was founded in Dongguan in March 2020, when reducers dominated robot power systems and direct drive — with its high technical barriers — drew little interest. Starting from three core capabilities in direct-drive motor design, thermal management and drive-control integration, the Company built three technology pillars: robotic actuator module technology, wheel-legged robot technology and modular reconfiguration technology, establishing an integrated R&D system spanning core components and robots. By eliminating reducers and other intermediate transmission components, direct drive couples the motor directly to the payload. The result is a simpler structure, higher positioning accuracy, lower noise and less wear — attributes suited to human-proximate applications such as household cleaning robots, where quietness and compact size matter most. On this differentiated route, the Company has become the world's first and only company to have shipped more than 5 million robotic direct drive actuator modules for consumer robots, according to Frost & Sullivan; by the end of June 2026, its technology had powered more than 7.5 million robots worldwide. Built on the three pillars, the Company's embodied joint module portfolio covers the mainstream size range from 20 mm to 120 mm, with peak torque outputs of up to 120 Nm. As of the Latest Practicable Date, it held 352 patents in China with 148 applications pending; 94.3% of its 192-member R&D team hold bachelor's degrees or above. In the consumer segment, the Company works with four of the world's top ten consumer robot providers by 2025 revenue. In embodied intelligence, it supplies embodied joint modules to one of China's top five embodied intelligence robot providers by total value of orders on hand in 2025. For its robot products, the Company has launched four wheel-legged robot models — Diablo, TITA, TITATIT and D1. Diablo robot is the first direct-drive dual-wheel-legged robot commercially introduced in the world; D1 is the first fully modular dual-wheel-legged robot commercially introduced in the world. The numbers now back the route. Revenue rose from RMB17.5 million in 2023 to RMB281.7 million in 2025, a CAGR of 300.8%, and grew a further 39.7% year on year to about RMB200 million in the first half of 2026. Gross profit margin climbed from 13.5% to 21.5% over the period, while the adjusted net loss margin (non-IFRS measure) narrowed sharply from 349.1% to 15.4% as economies of scale took hold. The Company plans to deploy about 50% of the net proceeds to R&D in key robotics technologies, including performance upgrades to robotic direct drive actuator modules and advances in robot and modular assembly technology; about 20% to deepen our collaboration with industry partners and wider domestic and overseas sales networks; about 20% to highly automated flexible production lines and process optimisation; and the remaining 10% to working capital and general corporate purposes. Frost & Sullivan expects the PRC direct drive actuator module market to grow from RMB1.9 billion in 2025 to RMB12.9 billion in 2030, and the country's embodied joint modules market to expand from RMB1.18 billion to RMB14.03 billion over the same period. The Company said it will capture the twin opportunities of direct drive substitution and the industrialisation of embodied intelligence, consolidate its segment leadership and create long-term value for shareholders. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com
Enefit OÜ, täielikult Eesti Energia AS’ile kuuluv tütarettevõte, avas 29. septembril 2026 Leedus ametlikult Kelmė I ja Kelmė II tuulepargid. Projektid lisavad Leedu elektrisüsteemi kokku 167 MW taastuvelektri tootmisvõimsust. Enefit investeeris tuuleparkide arendamisse ligikaudu 324 miljonit eurot.
On 29 September 2026, Enefit OÜ, wholey owned subsidiary of Eesti Energia AS, officially opened the Kelmė I and Kelmė II wind farms in Lithuania. The projects add a combined 167 MW of renewable electricity generation capacity to Lithuania's electricity system. Enefit invested approximately EUR 324 million in the development of the wind farms.
(PR-inside.com) SHELTON, CT / ACCESS Newswire / September 29, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2026 with the Securities and Exchange Commission (SEC) on Monday, September 28, 2026. The report can be accessed at the SEC website ( https://www.sec.gov/ix?doc=/Archives/edgar/data/0001379006/000110465926111390/nnvc-20260630x10k.htm ). Accomplishments in Reported Fiscal Year ending June 30, 2026 In the fiscal year 2026, we have achieved a substantial level of accomplishments. We have focused on regulatory advancement of our broad spectrum antiviral drug NV- 387. We received approval for Phase II clinical trial ..
(PR-inside.com) Funding through New York State's Rural Health Transformation Program will launch NY-VISTA, an 11-hospital collaborative designed to bring timely specialty expertise closer to rural patients and care teams NEW YORK, NY / ACCESS Newswire / September 29, 2026 / Ellenville Regional Hospital has been awarded $3 million through New York State's Rural Community Health Integration (RCHI) initiative, part of the State's Rural Health Transformation Program (RHTP), to implement NY-VISTA, a new 11-hospital rural specialty access collaborative. New York Virtual Integrated Specialty Telehealth Access (NY-VISTA) is designed to give emergency department and inpatient teams timely access to specialty expertise at critical points in ..
MONTRÉAL, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aeroplan, Canada’s leading loyalty program today announced a major refresh of its Canadian co-branded credit card portfolio with new benefits starting January 12, 2027, designed to elevate the travel journey. The upgrades build on Aeroplan’s category-leading offering, delivering savings to cardholders as they plan, book and enjoy travel.
MONTRÉAL, 29 sept. 2026 (GLOBE NEWSWIRE) -- Aéroplan, le principal programme de fidélité au Canada, a annoncé aujourd’hui une refonte majeure de son portefeuille canadien de cartes de crédit comarquées Aéroplan, lesquelles offriront, à compter du 12 janvier 2027, de nouveaux privilèges conçus pour rehausser l’expérience de voyage. Ces améliorations s’inscrivent dans l’offre de premier plan d’Aéroplan dans sa catégorie et permettent aux titulaires de carte de réaliser des économies à chaque étape du voyage.
HOUSTON, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced that it has completed and closed enrollment in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) for the treatment of adults with relapsed or refractory acute myeloid leukemia (R/R AML), with 89 subjects enrolled and an additional subject currently in screening. With Part A enrollment closed, the Company remains on track for its planned comprehensive data readout of Part A in the first quarter of 2027.
OMNIQ’s Q Shield platform has been selected for two municipal deployments in Pennsylvania, its first in the state. The two-year agreements cover 18 cameras